SSSøren Paludan Sheikh

Søren Paludan Sheikh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Søren Paludan Sheikh has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects

    by Pratibha Dhumale, Pratibha Dhumale, Pratibha Dhumale, Pratibha Dhumale, Jakob Vennike Nielsen, Jakob Vennike Nielsen, Jakob Vennike Nielsen, Jakob Vennike Nielsen, Anne Cathrine Schmidt Hansen, Anne Cathrine Schmidt Hansen, et al.

    Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+ ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+ ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+ ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+ ADRCs.


  • Open Access

    CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects

    by Pratibha Dhumale, Jakob Vennike Nielsen, Anne Cathrine Schmidt Hansen, Mark Burton, Hans Christian Beck, Mads Gustaf Jørgensen, Navid Mohamadpour Toyserkani, Martha Kirstine Haahr, Sabrina Toft Hansen, Lars Lund, et al.

    Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (=ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+ ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31- and parent ADRCs. When CD31+, CD31- and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+ ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+ ADRCs.

  • Open Access

    Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis

    by Rasmus Søgaard Hansen, Signe Hedengran Biørn, Johan Baden Birk‐Korch, Søren Paludan Sheikh, Mads Hvid Poulsen, Pernille Just Vinholt

    Objectives: To investigate the prevalence of prostate cancer in men attending evaluation for haematuria, as this could help healthcare providers to determine whether men with haematuria should have prostate examinations performed. Methods: The study was performed according to a pre‐specified protocol uploaded to the International Prospective Register of Systematic Reviews (PROSPERO; CRD42022299383). A systematic search of MEDLINE, Ovid and Google Scholar was performed in December 2021. Two independent researchers evaluated all titles, available abstracts, and full texts. We included studies on adult men (aged ≥18 years) describing haematuria and prostate cancer. Results: We screened 4252 titles and abstracts when available and assessed 350 studies in full text. In total, 65 studies were included and 42 was summarised in a meta‐analysis. In total, 18 752 men with haematuria were included, and the pooled prevalence (95% confidence interval [CI]) of prostate cancer was 3.0% (2.0–4.1%). In men with macroscopic haematuria, the pooled prevalence (95% CI) of prostate cancer was 5.9% (2.9–9.9%; n = 265/5373). In men with microscopic haematuria, the pooled prevalence (95% CI) of prostate cancer was 1.4% (0.8–2.2%; n = 71/6642). Conclusion: Our findings indicate that the prevalence of prostate cancer is considerable in men attending evaluation for haematuria. Therefore, digital rectal examination and prostate‐specific antigen measurement should become a standard procedure for all men with haematuria, especially for men with macroscopic haematuria.


  • Open Access

    Adipose-Derived Stem Cells from Type 2 Diabetic Rats Retain Positive Effects in a Rat Model of Erectile Dysfunction

    by Marlene Louise Quaade, Pratibha Dhumale, Simon Gabriel Comerma Steffensen, Hans Christian Beck, Eva Bang Harvald, Charlotte Harken Jensen, Lars Lund, Ditte Caroline Andersen, Søren Paludan Sheikh

    Erectile dysfunction is a common complication associated with type 2 diabetes mellitus (T2DM) and after prostatectomy in relation to cancer. The regenerative effect of cultured adipose-derived stem cells (ASCs) for ED therapy has been documented in multiple preclinical trials as well as in recent Pase 1 trials in humans. However, some studies indicate that diabetes negatively affects the mesenchymal stem cell pool, implying that ASCs from T2DM patients could have impaired regenerative capacity. Here, we directly compared ASCs from age-matched diabetic Goto–Kakizaki (ASCGK) and non-diabetic wild type rats (ASCWT) with regard to their phenotypes, proteomes and ability to rescue ED in normal rats. Despite ASCGK exhibiting a slightly lower proliferation rate, ASCGK and ASCWT proteomes were more or less identical, and after injections to corpus cavernosum they were equally efficient in restoring erectile function in a rat ED model entailing bilateral nerve crush injury. Moreover, molecular analysis of the corpus cavernosum tissue revealed that both ASCGK and ASCWT treated rats had increased induction of genes involved in recovering endothelial function. Thus, our finding argues that T2DM does not appear to be a limiting factor for autologous adipose stem cell therapy when correcting for ED.


  • Small Diameter Polycaprolactone Vascular Grafts are Patent in sheep Carotid Bypass but Require Antithrombotic Therapy

    by Shu Fang, Alexander Høgsted Ahlmann, Louise Langhorn, Kamal Hussein, Jens Ahm Sørensen, Xiaowei Guan, Søren Paludan Sheikh, Lars Peter Riber, Ditte Caroline Andersen

    Background: Polycaprolactone (PCL) scaffolds exhibit high biocompatibility and are attractive as vascular conduits. Materials & methods: PCL tubes were cultivated in bioreactor with human adipose r...


  • Open Access

    MESP1 knock-down in human iPSC attenuates early vascular progenitor cell differentiation after completed primitive streak specification

    by Tilde V. Eskildsen, Sohrab Ayoubi, Mads Thomassen, Mark Burton, Mohammed A. Mandegar, Bruce R. Conklin, Charlotte H. Jensen, Ditte C. Andersen, Søren P. Sheikh


  • Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential

    by Sohrab Ayoubi, Søren P. Sheikh, Tilde V. Eskildsen

    Cardiovascular diseases remain the leading cause of death worldwide and current treatment strategies have limited effect of disease progression. It would be desirable to have better models to study developmental and pathological processes and model vascular diseases in laboratory settings. To this end, human induced pluripotent stem cells (hiPSCs) have generated great enthusiasm, and have been a driving force for development of novel strategies in drug discovery and regenerative cell-therapy for the last decade. Hence, investigating the mechanisms underlying the differentiation of hiPSCs into specialized cell types such as cardiomyocytes, endothelial cells, and vascular smooth muscle cells (VSMCs) may lead to a better understanding of developmental cardiovascular processes and potentiate progress of safe autologous regenerative therapies in pathological conditions. In this review, we summarize the latest trends on differentiation protocols of hiPSC-derived VSMCs and their potential application in vascular research and regenerative therapy.


  • A 3-month age difference profoundly alters the primary rat stromal vascular fraction phenotype

    by Marlene Louise Quaade, Charlotte Harken Jensen, Ditte Caroline Andersen, Søren Paludan Sheikh


  • Open Access

    Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial

    by Martha Kirstine Haahr, Charlotte Harken Jensen, Navid Mohamadpour Toyserkani, Ditte Caroline Andersen, Per Damkier, Jens Ahm Sørensen, Lars Lund, Søren Paludan Sheikh


  • Persistent scarring and dilated cardiomyopathy suggest incomplete regeneration of the apex resected neonatal mouse myocardium — A 180 days follow up study

    by Ditte Caroline Andersen, Charlotte Harken Jensen, Christina Baun, Svend Hvidsten, David C. Zebrowski, Felix Benedikt Engel, Søren Paludan Sheikh